4-Methoxyphenyl 2-acetamido-3,6-di-O-acetyl-4-O-{2,4-di-O-acetyl-3-O-[3,6-di-O-acetyl-2,4-di-O-(3,4,6-tri-O-acetyl-2-acetamido-2-deo xy-b-D-glucopyranosyl)-a-D-mannopyranosyl]-6-O-[3,4-di-O-acetyl-2,6-di-O-(3,4,6-tri-O-acetyl-2-acetamido-2-deoxy-b-D-g

Ref. 3D-OM11008

Produktinformation

• Name: 4-Methoxyphenyl 2-acetamido-3,6-di-O-acetyl-4-O-{2,4-di-O-acetyl-3-O-[3,6-di-O-acetyl-2,4-di-O-(3,4,6-tri-O-acetyl-2-acetamido-2-deo xy-b-D-glucopyranosyl)-a-D-mannopyranosyl]-6-O-[3,4-di-O-acetyl-2,6-di-O-(3,4,6-tri-O-acetyl-2-acetamido-2-deoxy-b-D-g

Beschreibung

4-Methoxyphenyl 2-acetamido-3,6-di-O-acetyl-4-O-[2,4-di-O-(3,6,9)-triacetyldi-O-(3,4,6)-triacetyldiacetamido]-bDglucopyranoside (MPPA) is a modification of the natural oligosaccharide 3,6,-di-O-(2,4-di-O-(3,6,9)-triacetyldiacyl)-bDmannopyranosyl. MPPA is synthesized by methylation and glycosylation of glucose residues in the backbone of the natural oligosaccharide. The methylated glycosidic linkages are substituted for acetamido groups in order to confer water solubility to the molecule. MPPA has been shown to be an effective inhibitor of influenza virus replication in vitro.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 2,467.26 g/mol
• Formel: C₁₀₅H₁₄₃N₅O₆₂
• Reinheit: Min. 95%